SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023		Dec. 31, 2022
Movement in Valuation Allowances and Reserves [Abstract]
Balance at beginning of period	$ 53,811	$ 35,370		$ 31,921
Charged to expense	56,578	41,637		34,915
Accounts written-off	(44,817)	(23,196)	[1]	(31,466)
Balance at end of period	65,572	53,811		35,370
Accounts receivables	19,627	17,504
Retained earnings	79,170	69,279
Deferred tax asset	$ 25,359	$ 23,217
Cumulative Effect, Period of Adoption, Adjustment [Member] | ASC 326 [Member]
Movement in Valuation Allowances and Reserves [Abstract]
Accounts receivables				10,800
Retained earnings				(7,900)
Deferred tax asset				2,900
Allowance for Credit Loss [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member] | ASC 326 [Member]
Movement in Valuation Allowances and Reserves [Abstract]
Accounts receivables				10,800
Retained earnings				(7,900)
Deferred tax asset				$ 2,900

[1] On January 1, 2023, the Company adopted Accounting Standards Update No. 2016-13 Financial Instruments - Credit Losses. The adoption resulted in an opening balance sheet adjustments of $10.8 million increasing the allowance for credit losses relating to the Company’s outstanding receivables. The adoption also resulted in a decrease to retained earnings of $7.9 million, after tax and a deferred tax asset increase of $2.9 million.